128 related articles for article (PubMed ID: 14740808)
1. Intraocular leukemia as the primary manifestation of relapsing acute myelogenous leukemia.
Kassam F; Gale JS; Sheidow TG
Can J Ophthalmol; 2003 Dec; 38(7):613-6. PubMed ID: 14740808
[No Abstract] [Full Text] [Related]
2. Allogeneic transplantation versus intensive chemotherapy in first-remission acute leukemia: is there a "best choice"?
Mayer RJ
J Clin Oncol; 1988 Oct; 6(10):1532-6. PubMed ID: 3049948
[No Abstract] [Full Text] [Related]
3. Autologous blood stem cell transplantation versus autologous bone marrow transplantation for acute myeloid leukemia in first complete remission. The EBMT Group Working Party for Autologous Bone Marrow Transplantation.
Reiffers J; Korbling M; Labopin M; Gorin NC
Bone Marrow Transplant; 1991; 7 Suppl 2():144. PubMed ID: 1678976
[No Abstract] [Full Text] [Related]
4. Postremission therapy for the younger adult patient with acute myelogenous leukemia: defining a role for transplantation.
Hurd DD
J Clin Oncol; 1993 Sep; 11(9):1636-8. PubMed ID: 8204125
[No Abstract] [Full Text] [Related]
5. Possible neuroleukemiosis in two patients with acute myeloid leukemia in complete bone marrow remission.
Kostic I; Ruiz M; Branca A; Nabergoj M; Piazza F; Semenzato G; Gurrieri C; Briani C
J Neurol Sci; 2018 Sep; 392():63-64. PubMed ID: 30049661
[No Abstract] [Full Text] [Related]
6. Follow-up 26 years after treatment for acute myelogenous leukemia.
Clift RA; Thomas ED;
N Engl J Med; 2004 Dec; 351(23):2456-7. PubMed ID: 15575071
[No Abstract] [Full Text] [Related]
7. Leukemia relapse in host cells 5 years after bone marrow transplantation for acute non-lymphocytic leukemia in first complete remission.
van't Veer-Korthof ET; van Weel-Sipman MH; Hählen K; Heurkens AH; Vossen JM
Bone Marrow Transplant; 1988 Nov; 3(6):647-51. PubMed ID: 3063332
[TBL] [Abstract][Full Text] [Related]
8. Autologous marrow transplantation in first remission acute myeloid leukemia using marrow purged with mafosfamide.
Rizzoli V; Mangoni L; Carlo-Stella C; Carella AM; Coser P; Angrilli F; Porcellini A; Bernabei PA
Bone Marrow Transplant; 1991; 7 Suppl 2():37. PubMed ID: 1878710
[No Abstract] [Full Text] [Related]
9. [The role of bone marrow transplantation in the treatment of leukemia].
Robak T
Przegl Lek; 1990; 47(10):723-7. PubMed ID: 2089452
[No Abstract] [Full Text] [Related]
10. Chemotherapy versus transplantation: I. Acute myelogenous leukemia.
Gale RP; Butturini A
Haematologica; 1989; 74(1):1-4. PubMed ID: 2498172
[No Abstract] [Full Text] [Related]
11. Strategies for acute myelogenous leukemia.
Gale RP; Butturini A
Bone Marrow Transplant; 1991; 7 Suppl 2():58. PubMed ID: 1878721
[No Abstract] [Full Text] [Related]
12. Allogeneic versus autologous bone marrow transplantation (BMT) versus intensive consolidation in acute myelogenous leukemia (AML) in first remission. An EORTC-Gimema phase III trial (AML8 A). The EORTC Leukemia Cooperative Group and the GIMEMA Group.
Zittoun R; Mandelli F; Willemze R; de Witte T; Tura S; Ferrini PR; Stryckmans P; Gattringer C; Petti MC; Solbu G
Leukemia; 1992; 6 Suppl 2():114-5. PubMed ID: 1578909
[No Abstract] [Full Text] [Related]
13. Chemotherapy of acute myelogenous leukemia. A review.
Zittoun R
Leukemia; 1992; 6 Suppl 2():36-8. PubMed ID: 1578939
[No Abstract] [Full Text] [Related]
14. Bone marrow transplantation. The state of the art.
Thomas ED
Ann Ital Med Int; 1986 Jun; 1(2):109-14. PubMed ID: 3079358
[No Abstract] [Full Text] [Related]
15. Methodology of evaluation in EORTC trials including BMT in acute myelogenous leukemia (AML) in first complete remission (CR). EORTC Leukemia Cooperative Group (LCG) and GIMEMA.
Suciu S; Solbu G; Zittoun R; Hayat M; Willemze R; de Witte T; Mandelli F
Bone Marrow Transplant; 1991; 7 Suppl 2():34. PubMed ID: 1878707
[No Abstract] [Full Text] [Related]
16. BAVC regimen in CR AML patients.
Meloni G; Vignetti M; De Fabritiis P; Petti MC; Pinto MR; Testi AM; Vegna ML; Mandelli F
Bone Marrow Transplant; 1991; 7 Suppl 2():134. PubMed ID: 1878679
[No Abstract] [Full Text] [Related]
17. Allogeneic bone marrow transplantation in a program of intensive sequential chemotherapy for children and young adults with acute nonlymphocytic leukemia in first remission.
Dahl GV; Kalwinsky DK; Mirro J; Look AT; Pui CH; Murphy SB; Mason C; Ruggiero M; Schell M; Johnson FL
J Clin Oncol; 1990 Feb; 8(2):295-303. PubMed ID: 2299372
[TBL] [Abstract][Full Text] [Related]
18. Reasons that patients with acute myelogenous leukemia do not undergo allogeneic bone marrow transplantation.
Berman E; Little C; Gee T; O'Reilly R; Clarkson B
N Engl J Med; 1992 Jan; 326(3):156-60. PubMed ID: 1727546
[TBL] [Abstract][Full Text] [Related]
19. A comparison of marrow transplantation with chemotherapy for adults with acute leukemia of poor prognosis in first complete remission.
Zander AR; Keating M; Dicke K; Dixon D; Pierce S; Jagannath S; Peters L; Horwitz L; Cockerill K; Spitzer G
J Clin Oncol; 1988 Oct; 6(10):1548-57. PubMed ID: 3049949
[TBL] [Abstract][Full Text] [Related]
20. Patterns of relapse after bone marrow transplantation for chronic myeloid leukaemia.
Frassoni F; Sessarego M; Martinelli G; Strada P; Gualandi F; Lamparelli T; Pignatti PF; Defferrari R; Fugazza G; Bacigalupo A
Bone Marrow Transplant; 1991; 7 Suppl 2():17-8. PubMed ID: 1878694
[No Abstract] [Full Text] [Related]
[Next] [New Search]
